AZNCX
Price
$10.08
Change
-$0.00 (-0.00%)
Updated
Jan 13 closing price
Net Assets
4.79B
RLBGX
Price
$38.45
Change
-$0.05 (-0.13%)
Updated
Jan 13 closing price
Net Assets
269.72B
Interact to see
Advertisement

AZNCX vs RLBGX

Header iconAZNCX vs RLBGX Comparison
Open Charts AZNCX vs RLBGXBanner chart's image
Virtus Income & Growth C
Price$10.08
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets4.79B
American Funds American Balanced R6
Price$38.45
Change-$0.05 (-0.13%)
VolumeN/A
Net Assets269.72B
AZNCX vs RLBGX Comparison Chart in %
View a ticker or compare two or three
VS
AZNCX vs. RLBGX commentary
Jan 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZNCX is a Hold and RLBGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBGX has more cash in the bank: 270B vs. AZNCX (4.79B). RLBGX pays higher dividends than AZNCX: RLBGX (2.24) vs AZNCX (2.03). AZNCX was incepted earlier than RLBGX: AZNCX (19 years) vs RLBGX (17 years). AZNCX (1.90) is less costly to investors than RLBGX (0.25). AZNCX is a more actively managed with annual turnover of: 76.00 vs. RLBGX (44.00). RLBGX has a lower initial minimum investment than AZNCX: RLBGX (250) vs AZNCX (2500). RLBGX annual gain was more profitable for investors over the last year : 15.03 vs. AZNCX (6.60). RLBGX return over 5 years is better than : 38.26 vs. AZNCX (-6.70).
AZNCXRLBGXAZNCX / RLBGX
Total Expense Ratio1.900.25760%
Annual Report Gross Expense Ratio1.900.25760%
Fund Existence19 years17 years-
Gain YTD1.8182.50673%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.79B270B2%
Annual Yield % from dividends2.032.2491%
Returns for 1 year6.6015.0344%
Returns for 3 years15.9739.4540%
Returns for 5 years-6.7038.26-18%
Returns for 10 years22.8393.7224%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BMSDX15.200.01
+0.07%
MFS Blended Research Mid Cap Eq C
STRLX57.46N/A
N/A
Sterling Capital MdCp Relatv Val A
HGHAX39.35-0.10
-0.25%
Hartford Healthcare A
JHACX10.13-0.04
-0.39%
JHancock Multi-Asset Absolute Return C
VFSNX282.69-1.38
-0.49%
Vanguard FTSE All-Wld ex-US SmCp Idx Ins